Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IS
iSpecimen Inc. Common Stock
ISPC
Mkt Cap
$2.3M
Volume
45.15K
Next Earnings
November 16th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IS
ISPC
IS
iSpecimen Inc. Common Stock
ISPC
News
·
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Mkt Cap
$2.3M
Volume
45.15K
Next Earnings
November 16th
Chart
Financials
Earnings
News
About
Insider
Filings
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
iSpecimen Inc. (Nasdaq: ISPC) closed a $5 million public offering consisting of 996,231 shares of common stock and pre-funded warrants to purchase 2,849,923 shares. The company plans to use proceeds for debt repayment, potential acquisitions, marketing, and working capital. E.F. Hutton & Co. served as the exclusive placement agent.
GlobeNewswire Inc. · Aug 7, 2026
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
E.F. Hutton & Co. served as exclusive placement agent for iSpecimen Inc.'s $5 million public offering. This marks the third capital markets engagement between the two firms since December 2025. The capital will support iSpecimen's strategic priorities including liability repayment, potential acquisitions, marketing initiatives, and general corporate purposes.
GlobeNewswire Inc. · Aug 7, 2026
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
E.F. Hutton & Co. acted as exclusive placement agent for iSpecimen Inc.'s $2.5 million private placement, which closed on May 11, 2026. This marks the second financing transaction between the two companies in six months, following a $5.5 million placement in December 2025. iSpecimen operates an online marketplace connecting researchers with biospecimen providers for medical research.
GlobeNewswire Inc. · May 12, 2026
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
iSpecimen Inc. (Nasdaq: ISPC) announced a private placement offering of approximately $2.5 million in gross proceeds. The company will issue 488,281 shares at $5.12 per share, with net proceeds intended for working capital and marketing expenses. The offering is expected to close on May 11, 2026, subject to customary closing conditions and requires stockholder approval under Nasdaq Listing Rules.
GlobeNewswire Inc. · May 9, 2026
iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session
iSpecimen Inc. (NASDAQ: ISPC) shares surged 56.19% in after-hours trading to $0.20 following the announcement of a direct supplier-to-customer shipping overhaul that reduces domestic transit times by 70-85%, cutting delivery from 7-14 days to 1-2 days. The company also expanded rare specimen sourcing partnerships across Europe. However, the stock remains down 90.84% over the past 12 months and closed the regular session at $0.13.
Benzinga · Apr 10, 2026
Stock Market Today: S&P 500, Dow Jones Futures Down As Santa Rally Hopes Fade—Investors Await Initial Jobless Claims Report
U.S. stock futures declined on New Year's Eve as hopes for a year-end Santa Claus rally fade. Markets remain jittery following President Trump's threats against Federal Reserve Chair Jerome Powell. Investors await the Initial Jobless Claims report before market open. The S&P 500, Dow Jones, and Nasdaq 100 all traded lower in premarket, with several individual stocks showing significant moves based on company announcements and FDA approvals.
Benzinga · Dec 31, 2025
iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement
iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for biospecimens, announced a securities purchase agreement with accredited investors for approximately $5.5 million in gross proceeds. The company will issue 6,875 shares of Series C Convertible Preferred Stock at $800 per share, convertible into common stock at 85% of the closing price. Net proceeds will be used for marketing, working capital, and general corporate purposes, with the offering expected to close on December 31, 2025.
GlobeNewswire Inc. · Dec 30, 2025
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
iSpecimen Inc. closed a private placement of approximately $1.75 million by issuing 1,559,828 shares of common stock at $1.122 per share. The proceeds will be used for marketing services and general corporate purposes.
GlobeNewswire Inc. · Aug 4, 2025
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
iSpecimen Inc. closed a $4 million public offering of 5,714,283 shares at $0.70 per share. The company plans to use proceeds for marketing services, milestone payments, and general corporate purposes.
Benzinga · Jul 28, 2025
iSpecimen Inc. announces director resignation and shareholder meeting outcomes - Investing.com
iSpecimen Inc. announced the resignation of a director, the election of two new directors, and the approval of a reverse stock split at its annual shareholder meeting. The company also reported a decrease in revenue for Q1 2024 but highlighted a pipeline of new business opportunities.
Investing.com · Jul 22, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
IS
ISPC
iSpecimen Inc. Common Stock
Buy
Sell
Market
Limit
Soon
ISPC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any ISPC yet.
Related Tickers
Earnings